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Abstract
A gradually expanding body of literature suggests that Thyroid Hormone (TH) and Thyroid 
Hormone Receptors (TRs) play a contributing role in pancreatic and islet cell development, 
maturation, and function. Studies using a variety of model systems capable of exploiting species-
specific developmental paradigms have revealed the contribution of TH to cellular differentiation, 
lineage decisions, and endocrine cell specification. Moreover, in vitro and in vivo evidence 
suggests that TH is involved in islet β cell proliferation and maturation; however, the signaling 
pathway(s) connected with this function of TH/TR are not well understood. The purpose of this 
review is to discuss the current literature that has defined the effects of TH and TRs on pancreatic 
and islet cell development and function, describe the impact of hyper- and hypothyroidism on 
whole body metabolism, and highlight future and potential applications of TH in novel therapeutic 
strategies for diabetes.
Keywords
Thyroid hormone; Thyroid hormone receptor; Pancreatic islet; β cell; Insulin secretion
INTRODUCTION
The pancreas is a compound digestive gland, comprised of an exocrine and an endocrine 
compartment that secrete digestive enzymes and hormones, respectively. The exocrine 
pancreas is comprised of duct and acinar cells, whereas the endocrine pancreas is organized 
into structures known as the islets of Langerhans [1]. While endocrine mass comprises only 
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~2% of the total pancreas mass, the contribution of hormone-producing endocrine cells to 
whole body metabolism is significant. Decades of studies focused on development of the 
pancreas in the mouse (Mus musculus) have uncovered the structural organization of this 
organ from the fetal and perinatal stages through to the adult. As these studies demonstrate, 
understanding structure often lends great insight into function.
In the mouse, pancreas development begins around embryonic day (E) 8.5 when cells of the 
foregut endoderm begin to express markers that instruct pancreas formation. The dorsal and 
ventral pancreatic buds evaginate from the primitive gut tube due to signals from the 
adjacent mesoderm [2]; the progenitor cells that comprise the buds co-express Pdx1 
(pancreatic and duodenal homeobox 1) and Ptf1a (pancreatic transcription factor 1a) [3]. 
The stage of embryonic pancreas development from E9.5 to E12.5 is known as the primary 
transition (reviewed in [4]) during which progenitor cells in the dorsal and ventral epithelial 
buds organize into an epithelial arbor structure with both “tip” and “trunk” domains, as well 
as a few early differentiated “first wave” endocrine cells (composed mostly of glucagon-
expressing α cells [5]). The secondary transition[6] is characterized mainly by the 
differentiation and expansion of the endocrine and exocrine cell populations. In particular, 
multipotent progenitor cells in the “tip” domain (Cpa1+ (carboxypeptidase A1), Ptf1a+, 
Cmyc+ (myelocytomatosis oncogene)) give rise to acinar cells, whereas progenitor cells in 
the “trunk” domain (Neurog3+) delaminate from the epithelial cords and differentiate into 
the hormoneexpressing endocrine cells, including β (insulin), α (glucagon), δ (somatostatin), 
PP (pancreatic polypeptide), and ε (ghrelin) cells [7]. The existence of distinct domains of 
progenitor cells, which give rise to the differentiated cell populations in the developing 
pancreas, suggests that fate decisions may be decided in these early progenitor cells [8,9]; 
however, recent studies have also begun to shed light on the plasticity of differentiated 
pancreatic cells [10-13]. While the current body of work is quite limited, Thyroid Hormone 
(TH) and the Thyroid Hormone Receptors (TRs) may be factors of significance to pancreatic 
and islet cell development, maturation, and function.
PANCREAS AND ISLET DEVELOPMENT
The deiodination of the precursor thyroxine (T4) permits the synthesis of thyroid hormone 
(3,5,3′-triiodo-L-thyronine; T3; TH). The subsequent action of T3 is mediated by two 
Thyroid Hormone Receptors (TRs). The genes that encode TRα (Thra; Nr1a1) and TRβ 
(Thrb; Nr1a2) contain alternative promoters and splice variants ultimately resulting in the 
production of four mRNAs and the synthesis of four nuclear receptors – TRα1, TRβ1, TRβ2, 
TRβ3 [14]. The action and antagonism of the receptors is quite complex, and numerous 
mouse models have been generated to dissect the function of TH and the various TR 
isoforms. With regard to gene expression, TRα and TRβ are differentially expressed, 
resulting in distinct protein expression patterns. Certain TRα isoforms are ubiquitous, 
whereas others are specifically expressed in the intestine [15]. While also widely expressed, 
TRβ isoforms are found in liver, pituitary, hypothalamus, inner ear, retina, kidney, lung, 
skeletal muscle, heart, spleen and brain [14]. With respect to the pancreas, the expression of 
TR isoforms is noted in rat pancreas [16,17] and mouse islets [18]; however, the expression 
pattern of TH and the TRs has not been carefully examined at the cellular level in the 
embryonic pancreas. Aiello and colleagues [19] assessed the abundance of TRα and TRβ 
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mRNA transcript in whole embryonic pancreas from E12.5 through postnatal day (P) 0 
(birth). Specifically, TRα is expressed at E12.5 and steadily increases as pancreas 
development proceeds until reaching a maximum at birth (P0). In contrast, expression of 
TRβ is nearly undetectable from E12.5 to E15.5 and then rises dramatically in late 
development (E17.5) and at birth [19]. While the expression of TH or the TRs within 
specific cell populations in the embryonic pancreas still remains unknown, the identification 
of mRNA transcript suggests that TH signaling may occur during mouse pancreas 
development.
Knock-out and knock-in mouse models used to investigate the function of TR isoforms 
demonstrate no gross morphological changes in the pancreas; however, it should be noted 
that the pancreas is not the specific focus of the investigations that prompted the generation 
of the deletion mutants. Additionally, given the complex nature of the TR gene loci it is not 
surprising that multiple phenotypes are observed in various mouse models. Highlighting 
only a few of the mouse models of TRα, these studies have identified that loss of TRα1 
alters thermogenesis, lipogenesis and maturation of the neonatal brain [20]. Homozygous 
loss of both TRα1 and TRα2 results in hypothyroidic mice that also display growth arrest, a 
delay in maturation of the small intestine and bones, and death by five weeks of life [21]. 
The mutation of TRα that also affects the naturally truncated TRΔα isoform (transcribed 
from an internal promoter located in intron 7), demonstrates that TRα is important for 
intestinal maturation as well as transcriptional activation of the intestine-specific genes Cdx1 
(caudal type homeobox transcription factor 1) and Cdx2 (Caudal type homeobox 
transcription factor 2) [15]. With respect to loss of the TRβ isoform, deletion of TRβ alone 
alters the hypothalamic-pituitary-thyroid axis, the retina, and impairs hearing [22]. The 
generation of mice with a homozygous TRβ mutation that is also found in humans (TRβPV) 
results in severe dysfunction of the pituitary-thyroid axis, impaired weight gain and 
abnormal bone development, which is a distinct phenotype compared with the TRβ null 
mutant [23]. Interestingly, when the TRα and TRβ mutations are combined, mice are viable 
but display severe growth reduction, hypothermia and hearing impairment [24]. Overall, 
these studies point to loss of TRs having a profound effect on the normal development and 
function of many organs; however, the necessity and function of TRs for pancreas 
development and/or pancreatic and islet cell function remains a fairly understudied area of 
research. As will be discussed in the following section, there is mounting evidence that TH 
plays a functional role in pancreatic cell fate decisions, as well as structural organization of 
the pancreatic organ proper.
CELLULAR DIFFERENTIATION
The process of cellular differentiation is critical to the development of all organs, and 
various model organisms have been used to understand the stages or processes involved in 
how the pancreas develops. The mouse (Mus musculus) is the most widely used model 
system for studies investigating mammalian physiology and metabolism; however, this 
model has also been used to decipher key factors that instruct or influence pancreatic 
organogenesis. Additionally, zebrafish (Danio rerio), the African clawed frog (Xenopus 
laevis), and the chicken (Gallus gallus) exhibit species-specific experimental advantages for 
pancreatic studies. For example, given the complicated models/genetics required to study 
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pancreas regeneration in the mouse [10], tools generated using the zebrafish model system 
have greatly enlightened our understanding of pancreas and β cell regeneration [25].
A unique aspect of Xenopus/amphibian development is the requirement of TH for the 
process of organ development to proceed. Specifically, the formation of the skin, brain, 
intestine, liver and pancreas in the tadpole/frog requires the transformation or remodeling of 
these tissues in order for the mature organ to be formed; a process known as 
“metamorphosis” [26,27]. At metamorphosis, TH levels increase and after the metamorphic 
climax, TH levels revert to baseline [26]. The simultaneous effect on pancreas development 
is quite dramatic, such that mRNAs that encode terminally differentiated enzymes decline in 
response to increased TH, and the pancreas dramatically loses ~80% of its volume by the 
middle of the metamorphic climax [28]. This process of exocrine pancreas “regression” 
includes the dedifferentiation of acinar cells, which is controlled by TH, and subsequent re-
differentiation after metamorphic climax resulting in the formation of the adult exocrine 
pancreas as well as a ductal tree [28]. Interestingly during the eight days of metamorphic 
climax, pre-existing β cells scattered throughout the pancreas cluster into islet structures due 
to both the increase in TH as well as the interaction with the surrounding dedifferentiated 
acinar cells [29]. By two months following completion of metamorphosis, the exocrine 
pancreas reforms and contains acinar cells, a structured ductal network, and cell clusters that 
have replicated and expanded (reviewed in [27]). These studies demonstrate the specific 
influence of TH on pancreatic organogenesis in Xenopus.
The influence of TH on mammalian pancreas development is gradually being resolved. 
Aiello and colleagues utilized the tissue explant culture system to treat E12.5 mouse 
pancreas explants with T3 (3,5,3′-triiodo-L-thyronine) for 7 days, and demonstrate an 
increase in pancreatic ductal markers [19]. Moreover, when T3 is removed from the culture, 
the ductal cells in the T3-treated explants possess the ability to differentiate into endocrine 
cells, first up-regulating the pro-endocrine gene Neurog3 and then completing differentiation 
into endocrine cells, including those expressing insulin or glucagon [19]. Interestingly, T3 
treatment also induces pro-endocrine gene expression in the mouse acinar cell line 266-6 
[19], and β cell-specific gene expression in the ductal human pancreatic cell line hPANC1 
[30]. Furthermore, Furuya and colleagues demonstrate that acinar cells infected with an 
adenovirus vector expressing TRα driven by the Amylase2 promoter could be reprogrammed 
into insulin-producing β cells [31]. This work adds to the increasing number of reports 
identifying cellular plasticity in the pancreas, such that pancreatic cells are capable of both 
trans-differentiation and regeneration [10-13].
Islet (β cell) maturation, growth, and function
An elegant study by Aguayo-Mazzucato and colleagues describes the role of TH and TRs in 
postnatal rat islet maturation [16]. Specifically, T3 supplementation from birth through the 
first week of life (P7) results in an increase in body weight, pancreatic weight and β cell 
proliferation, while T3 treatment of rat islets isolated at P7 causes increased glucose-
stimulated insulin secretion. Interestingly, the authors also demonstrate that TR directly 
binds and activates the MafA gene promoter, providing evidence that T3 supplementation 
coordinately increases expression of MafA. Furthermore, T3-induced increases in GSIS 
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could be blocked with the use of a dominant negative form of MafA [16], ultimately 
identifying a role for TH in early postnatal islet cell function.
Additional evidence of the role for TH in pancreatic islet function comes from in vitro 
culture systems where T3 treatment of insulinoma cells or cultured islets results in preserved 
viability and β cell proliferation under basal and stress conditions. These results are 
attributed to activation of phosphoinositide 3-kinase/protein kinase B (PI3K/AKT) signaling 
through the non-genomic effects of TRβ [32-34]. In vivo, administration of T3 attenuates β 
cell death and improves glucose intolerance in mice treated with streptozotocin, and these 
effects are likewise associated with increased activation of AKT [35].
A direct relationship between TH and glucose tolerance?
Despite the positive effects of T3 on β cell function observed using in vitro and ex vivo 
model systems, hyperthyroidism is associated with impaired glucose tolerance, which has 
been attributed to several different mechanisms including impaired insulin action, increased 
gluconeogenesis, excess lipolysis, increased serum free fatty acid levels, and decreased 
insulin secretion. In aggregate, this body of literature suggests a combination of peripheral 
insulin resistance and impaired β cell function [36-39]. However, older studies demonstrate 
that an increase in intestinal absorption of carbohydrates also contributes to the hyperthyroid 
state [40]. Mechanistic studies have also begun to investigate the association between 
autoimmune hyperthyroidism and increased levels of proinflammatory cytokines, such as 
IL-18, that may contribute to metabolic derangements in concert with elevated thyroid 
hormone levels [41].
Hypothyroidism can lead to alterations in glucose tolerance. The pharmacological induction 
of hypothyroidism in dogs results in reduced insulin sensitivity with a concomitant increase 
in the acute insulin response to glucose [42]. In rats made acutely hypothyroid, with either 
surgery or anti-thyroid drugs, glucose tolerance is also impaired; however studies in humans 
identify that the resolution of even mild or subclinical hypothyroidism leads to an 
improvement in insulin sensitivity as assessed by hyperinsulinemic-euglycemic clamp [43]. 
Clearly the precise effects of hypothyroidism on islet function have not been completely 
resolved given that the ex vivo and in vivo assessment of islet function in response to 
alterations in thyroid hormone status have yielded varying results.
CONCLUSION
While the current body of literature examining the role of TH and TRs in the β cell is 
limited, several key studies have identified an important role for TH in pancreatic 
development, islet cell growth and β cell function. Continued research in these areas is 
needed to: (1) determine whether TH could be included as a potential molecule in in vitro 
differentiation protocols to assist in the differentiation of insulin-producing β cells, (2) 
understand the benefit of TH as a novel therapeutic in paradigms such as islet 
transplantation, and (3) resolve the relationship between hyperand hypothyroidism and 
altered β cell function. These areas of inquiry are ripe for further exploration and many 
unanswered questions await investigation.
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ABBREVIATIONS
E Embryonic day
Pdx1 Pancreatic and Duodenal Homeobox 1
Ptf1a Pancreatic Transcription Factor 1a
Cpa1 Carboxypeptidase A1
Cmyc Myelocytomatosis oncogene
TH Thyroid Hormone
T4 Thyroxine (T4)
T3 3,5,3′-Triiodo-L-Thyronine
TR Thyroid Hormone Receptors
P Postnatal day
Cdx1 Caudal Type Homeobox Transcription Factor 1
Cdx2 Caudal Type Homeobox Transcription Factor 2
PI3K Phosphoinositide 3-Kinase
AKT Protein Kinase B
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